'Revolutionary' New Drug for Prostate Cancer - BBC Website
Thursday, 3rd October 2019
Olaparib could become a revolutionary treatment for prostate cancer - the first genetically targeted drug for fighting the disease, say experts. The precision medicine is already used by the NHS for ovarian cancer and has been called a game-changer by cancer doctors.
A cancer conference heard how, in trials, it slowed tumour growth in men with advanced prostate cancer.
This could improve survival for some men, researchers hope.
Experts say it could be made available to patients in the next couple of years.
The drug, made by AstraZeneca, was fast-tracked to NHS ovarian cancer patients in England, paid for through the Cancer Drugs Fund, in July.
Click here to read the full artice on the BBC News website
Group Meeting and Jacob's Table at Leighton Hospital, Crewe
9 Nov 2019 10:00–12:00
PSA Testing Lymm Golf Club
23 Nov 2019 00:00–00:00